glp-1 compounding lawsuit Antitrust Case: Visibility vs. Market Barriers Beyond weight loss—how the GLP-1
Description
J Clin Psychiatry 2026;87(3):26br16352 Submitted: January 30, 2026
Gastroenterology (2011) 140:90312
(Individual results may vary)
Guglielmi G
It covers them only when prescribed for an FDA-approved non-weight indication: Check your GLP-1 eligibility Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy
